Showing results (271-280 of 311) with videos related to
Sort By:
Pageof 32
International Journal of Clinical Pharmacology and Therapeutics|October 6, 1998
Plasma coenzyme Q10 concentrations in breast cancer: prognosis and therapeutic consequencesP Jolliet, N Simon, J Barré, et al.Annales Pharmaceutiques Francaises|October 14, 2008
[Illicit drugs, medications and traffic accidents]J-P Goullé, A Verstraete, R Boulu, et al.Nuclear Medicine Communications|February 1, 1987
Interactions of phenylalkylamines with human lung membrane and microsome preparationJ L Moretti, R Zini, D Morin, et al.Pharmaceutical Research|June 1, 1999
The pH-partition profile of the anti-ischemic drug trimetazidine may explain its reduction of intracellular acidosisF Reymond, G Steyaert, P A Carrupt, et al.Annales De Biologie Clinique|January 1, 1984
[Comparison of bacteriological and immunoenzyme methods for the serum determination of sisomicin. Pharmacokinetic application in the human]A M Clausse, G Houin, J Barre, et al.The Journal of Pharmacology and Experimental Therapeutics|June 17, 1998
Effects of trimetazidine on lipid peroxidation and phosphorus metabolites during cold storage and reperfusion of isolated perfused rat kidneysT Hauet, G Bauza, J M Goujon, et al.The Biochemical Journal|March 1, 1995
Mechanism of ligand binding to alpha 1-acid glycoprotein (orosomucoid): correlated thermodynamic factors and molecular parameters of polarityS Urien, Y Giroud, R S Tsai, et al.Biochemical Pharmacology|August 15, 1987
Effect of erythrocytes and plasma protein binding on the transport of progabide and SL 75102 through the rat blood-brain barrierC Hamberger, S Urien, D Essassi, et al.European Journal of Pharmacology|September 26, 1996
Pharmacokinetically guided melatonin scheduling in rats with circadian system suppressionP Deprés-Brummer, G Metzger, D Morin, et al.Pharmaceutical Research|May 1, 1997
Blood-to-brain transfer of various oxicams: effects of plasma binding on their brain deliveryP Jolliet, N Simon, F Brée, et al.Pageof 32